GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (STU:36M) » Definitions » Research & Development

Shockwave Medical (STU:36M) Research & Development : €150.7 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shockwave Medical Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Shockwave Medical's Research & Development for the three months ended in Mar. 2024 was €40.9 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €150.7 Mil.


Shockwave Medical Research & Development Historical Data

The historical data trend for Shockwave Medical's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical Research & Development Chart

Shockwave Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 29.57 30.35 44.73 77.11 133.56

Shockwave Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.19 33.99 37.04 38.81 40.91

Shockwave Medical Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €150.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shockwave Medical  (STU:36M) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Shockwave Medical Research & Development Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Shockwave Medical (STU:36M) Business Description

Traded in Other Exchanges
Address
5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.

Shockwave Medical (STU:36M) Headlines

No Headlines